CN Patent

CN106316964B — 苯基氨基嘧啶化合物或其盐的多晶型物

Assigned to Suzhou Zehuang Biopharmaceutical Co Ltd · Expires 2019-06-25 · 7y expired

What this patent protects

本发明涉及苯基氨基嘧啶化合物或其盐的多晶型物，具体地，涉及N‑(氰基甲基)‑4‑(2‑(4‑(2',2',6',6'‑d 4 ‑吗啡啉)苯基氨基)嘧啶‑4‑基)苯甲酰胺、或其药学上可接受的盐、或其溶剂合物的多晶型物，即式I所示化合物或其盐、或其溶剂合物的多晶型物。所述多晶型物适合用于制备抑制非受体酪氨酸激酶(如JAK激酶)的药物组合物。

USPTO Abstract

本发明涉及苯基氨基嘧啶化合物或其盐的多晶型物，具体地，涉及N‑(氰基甲基)‑4‑(2‑(4‑(2',2',6',6'‑d 4 ‑吗啡啉)苯基氨基)嘧啶‑4‑基)苯甲酰胺、或其药学上可接受的盐、或其溶剂合物的多晶型物，即式I所示化合物或其盐、或其溶剂合物的多晶型物。所述多晶型物适合用于制备抑制非受体酪氨酸激酶(如JAK激酶)的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN106316964B
Jurisdiction
CN
Classification
—
Expires
2019-06-25
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Zehuang Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.